This conference focuses on outcomes research in chronic kidney disease and end-stage kidney disease, delivery of care in dialysis units and chronic kidney disease clinics, emerging data on new treatments compared to current standard fo care, review of kidney pathology, and basic science research that may become future therapeutics.
Key Words: Nephrology, Clinical Trials, Research
- Physicians
- Nurse Practitioners
- Physician Assistants
- Trainees, Medical Students
Participants who engage in this educational intervention will be able to:
- Describe the proposed pathophysiologic mechanisms for endothelin involvement in chronic kidney disease.
- Analyze results from the PRECISION trial of a dual endothelin receptor antagonist in the treatment of resistant hypertension.
- Examine results from the ZENITH-CKD trial of a selective endothelin A receptor antagonist in patients with chronic kidney disease.
- Discuss how endothelin receptor antagonists may fit into the future therapeutic regimen available to nephrologists.
- Dawn Wolfgram
- Paul Merchant
Contact
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.

Facebook
X
LinkedIn
Forward